相似文献
1
Molecular Discriminators of Racial Disparities in Prostate Cancer.
Trends Cancer. 2016 Mar;2(3):116-120. doi: 10.1016/j.trecan.2016.01.005. Epub 2016 Feb 11.
2
Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location.
Eur Urol. 2016 Jul;70(1):14-17. doi: 10.1016/j.eururo.2015.09.031. Epub 2015 Oct 9.
3
TMPRSS2:ERG Gene Fusions in Prostate Cancer of West African Men and a Meta-Analysis of Racial Differences.
Am J Epidemiol. 2017 Dec 15;186(12):1352-1361. doi: 10.1093/aje/kwx235.
4
Comparison of ERG and SPINK1 expression among incidental and metastatic prostate cancer in Japanese men.
Prostate. 2019 Jan;79(1):3-8. doi: 10.1002/pros.23705. Epub 2018 Jul 26.
5
TMPRSS2-ERG fusions linked to prostate cancer racial health disparities: A focus on Africa.
Prostate. 2019 Jul;79(10):1191-1196. doi: 10.1002/pros.23823. Epub 2019 May 15.
6
Clonal evaluation of early onset prostate cancer by expression profiling of ERG, SPINK1, ETV1, and ETV4 on whole-mount radical prostatectomy tissue.
Prostate. 2020 Jan;80(1):38-50. doi: 10.1002/pros.23914. Epub 2019 Oct 4.
7
Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes.
Eur Urol. 2015 Oct;68(4):555-67. doi: 10.1016/j.eururo.2015.04.033. Epub 2015 May 8.
8
Molecular alterations in prostate cancer and association with MRI features.
Prostate Cancer Prostatic Dis. 2017 Dec;20(4):430-435. doi: 10.1038/pcan.2017.33. Epub 2017 Aug 1.
9
Evidence for molecular differences in prostate cancer between African American and Caucasian men.
Clin Cancer Res. 2014 Sep 15;20(18):4925-34. doi: 10.1158/1078-0432.CCR-13-2265. Epub 2014 Jul 23.
10
Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-ERG and SPINK1 as serum biomarkers.
BJU Int. 2012 Sep;110(6):840-5. doi: 10.1111/j.1464-410X.2011.10922.x. Epub 2012 Feb 7.
引用本文的文献
1
GraphPath: a graph attention model for molecular stratification with interpretability based on the pathway-pathway interaction network.
Bioinformatics. 2024 Mar 29;40(4). doi: 10.1093/bioinformatics/btae165.
2
Integrated high-throughput analysis identifies super enhancers in metastatic castration-resistant prostate cancer.
Front Pharmacol. 2023 May 24;14:1191129. doi: 10.3389/fphar.2023.1191129. eCollection 2023.
3
The Expression of Proto-Oncogene () Plays a Central Role in the Oncogenic Mechanism Involved in the Development and Progression of Prostate Cancer.
Int J Mol Sci. 2022 Apr 26;23(9):4772. doi: 10.3390/ijms23094772.
4
Comprehensive signature analysis of drug metabolism differences in the White, Black and Asian prostate cancer patients.
Aging (Albany NY). 2021 Jun 18;13(12):16316-16340. doi: 10.18632/aging.203158.
5
TP53 alterations of hormone-naïve prostate cancer in the Chinese population.
Prostate Cancer Prostatic Dis. 2021 Jun;24(2):482-491. doi: 10.1038/s41391-020-00302-3. Epub 2020 Nov 19.
6
Insights into disparities observed with COVID-19.
J Intern Med. 2021 Apr;289(4):463-473. doi: 10.1111/joim.13199. Epub 2020 Dec 6.
7
Epigenetic Silencing of miRNA-338-5p and miRNA-421 Drives SPINK1-Positive Prostate Cancer.
Clin Cancer Res. 2019 May 1;25(9):2755-2768. doi: 10.1158/1078-0432.CCR-18-3230. Epub 2018 Dec 26.
8
TMPRSS2:ERG Gene Fusions in Prostate Cancer of West African Men and a Meta-Analysis of Racial Differences.
Am J Epidemiol. 2017 Dec 15;186(12):1352-1361. doi: 10.1093/aje/kwx235.
9
Racial/Ethnic Disparities in Genomic Sequencing.
JAMA Oncol. 2016 Aug 1;2(8):1070-4. doi: 10.1001/jamaoncol.2016.1854.
本文引用的文献
1
The Molecular Taxonomy of Primary Prostate Cancer.
Cell. 2015 Nov 5;163(4):1011-25. doi: 10.1016/j.cell.2015.10.025.
2
Integrative clinical genomics of advanced prostate cancer.
Cell. 2015 May 21;161(5):1215-1228. doi: 10.1016/j.cell.2015.05.001.
3
Molecular profiling of ETS and non-ETS aberrations in prostate cancer patients from northern India.
Prostate. 2015 Jul 1;75(10):1051-62. doi: 10.1002/pros.22989. Epub 2015 Mar 23.
4
Evidence for molecular differences in prostate cancer between African American and Caucasian men.
Clin Cancer Res. 2014 Sep 15;20(18):4925-34. doi: 10.1158/1078-0432.CCR-13-2265. Epub 2014 Jul 23.
5
Prostate cancer in Asian men.
Nat Rev Urol. 2014 Apr;11(4):197-212. doi: 10.1038/nrurol.2014.42. Epub 2014 Mar 4.
6
Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancer.
Urology. 2012 Oct;80(4):749-53. doi: 10.1016/j.urology.2012.07.001. Epub 2012 Aug 28.
7
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.
Nat Genet. 2012 May 20;44(6):685-9. doi: 10.1038/ng.2279.
8
Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells.
Cancer Res. 2010 Dec 1;70(23):9544-8. doi: 10.1158/0008-5472.CAN-10-1638. Epub 2010 Oct 14.
9
TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients.
Prostate. 2011 Apr;71(5):489-97. doi: 10.1002/pros.21265. Epub 2010 Sep 28.
10
8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC.
Proc Natl Acad Sci U S A. 2010 May 25;107(21):9742-6. doi: 10.1073/pnas.0910668107. Epub 2010 May 7.
Zotero 插件